Building Blocks

<p>5,7-Dimethyladamantane-1,3-diol is a diester that can be used as a surfactant in cosmetics and pharmaceuticals. It is a trimethylolpropane ester of the aliphatic diester neopentyl glycol. This compound has physicochemical properties such as solubility in both water and alcohol, high boiling point, low volatility, high viscosity and flashpoint. 5,7-Dimethyladamantane-1,3-diol also has a molecular formula of C10H26O4 and molecular weight of 256.24 g/mol.</p>

<p>3-Methyl-4-phenyl-1,2,5-oxadiazole is a nitrophenyl derivative that has been shown to have antimicrobial activity. It was used in antimicrobial screening and found to inhibit the growth of various bacteria. 3-Methyl-4-phenyl-1,2,5-oxadiazole inhibits bacterial growth by inhibiting the production of furoxan (a product of bacterial metabolism) through an unknown mechanism. Furoxan is a potent inhibitor of respiratory electron transport and prevents oxidative phosphorylation. 3-Methyl-4-phenyl 1,2,5 oxadiazole also inhibits the synthesis of cellular proteins and nucleic acids.</p>

<p>4-Phenyl-1,2,5-oxadiazol-3-amine is an analog of histamine that acts as a competitive antagonist at the H2 receptor. This compound has been shown to elicit histamine release in guinea pig tissues and to act as a competitive antagonist at the H2 receptor. It also blocks histamine binding to other receptors and has been shown to have antihistaminic properties. 4-Phenyl-1,2,5-oxadiazol-3-amine binds in a similar fashion as cimetidine and ranitidine with high affinity for the H2 receptor and lower affinity for the H1 receptor. This drug has also been shown to inhibit guinea pig ileum contractions and rat vas deferens contractions induced by histamine. The molecular weight of this compound is 169.4 g/mol and its chemical formula is C9H7N3O3. The structural formula is:</p>

<p>Versatile small molecule scaffold</p>

<p>7-Methylquinoxaline-6-carboxylic acid is a benzylic amino acid receptor antagonist. It binds to the excitatory amino acid receptors, which are proteins that bind to excitatory amino acids such as glutamate and aspartate. This binding prevents the excitatory amino acids from activating the receptor and initiating a series of reactions that lead to the release of neurotransmitters from the presynaptic neuron. 7-Methylquinoxaline-6-carboxylic acid has been shown to inhibit microbial growth, including bacteria, fungi, and yeast. It also inhibits rat brain activity in vitro at micromolar concentrations.</p>

<p>Versatile small molecule scaffold</p>

<p>N-Benzylfuran-2-carboxylic acid amide is an experimental drug that has been shown to have activity against tuberculosis. It is a benzylamide with a carbene ligand and a dehydrogenative reaction mechanism. N-Benzylfuran-2-carboxylic acid amide has also been shown to be effective in the synthesis of furan, carboxylic acids, sulfones, and galacturonic acids. The mechanism of action for this drug is not yet clear, but it may involve catalysis or binding to bacterial DNA.</p>

<p>1,4-Dimethylpiperidin-4-ol is an antiepileptic drug that belongs to the group of hydantoins. It is a potent and selective blocker of voltage-gated Na+ channels. This activity correlates with maximal inhibition at low concentrations, while minimal effects are seen at higher concentrations. 1,4-Dimethylpiperidin-4-ol has been shown to have antiepileptic and anesthetic properties in animal models. In addition, this drug has neurotoxic effects in animals.</p>

<p>Versatile small molecule scaffold</p>

<p>The N-[(4-Nitrophenyl)methyl]aniline is a chemical compound. It is an organic molecule that has a nitro group attached to the aniline group. This product is used as a catalyst in organic synthesis, specifically for the reduction of nitroarenes. The N-[(4-Nitrophenyl)methyl]aniline has been shown to be effective in the reduction of divinylbenzene and polystyrene. This catalyst can be used in many different reactions, such as crosslinking of borohydride ethers and kinetic measurements. The kinetics of this catalyst are dependent on the concentration of substrate, which can be controlled by varying the amount of sodium borohydride used.</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>3-Oxo-N-phenylbutanethioamide is a bidentate ligand that binds to metals. It has been shown to be an effective alkylsulfonyl and activated donor in biomolecular reactions with alkoxycarbonyl groups. 3-Oxo-N-phenylbutanethioamide can exist as two different isomers, cis and trans. The cis isomer was found to be more reactive than the trans isomer in x-ray diffraction data. This ligand also has a strong affinity for chlorine, which makes it useful for oxidant reactions as well as cycloacylation with nitro groups. 3-Oxo-N-phenylbutanethioamide displays a variety of functionalities, such as its ability to act as a ligand and an oxidant, making it an attractive molecule for research purposes.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4,6-Dichloro-N-methylpyrimidin-2-amine is an analog of pyrimidine that has been used in the synthesis of a number of drugs. The compound was first synthesized by condensation of 2,4,6-trichloropyrimidine with formaldehyde and sodium hydroxide. 4,6-Dichloro-N-methylpyrimidin-2-amine can be converted to the corresponding hydrochloride salt by treatment with hydrochloric acid. The compound reacts with methanol to produce methylamine. It also undergoes acid hydrolysis to produce methyl chloride and formaldehyde.</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Hexamethylmelamine is an analog of 6-hydrazinyl-N2,N2,N4,N4-tetramethyl-1,3,5-triazine-2,4-diamine. Hexamethylmelamine is a precursor to the antitumor drug hexamethylmelamine mustard. Hexamethylmelamine mustard is a cytotoxic alkylating agent that reacts with DNA and RNA in the cell nucleus. The reaction between hexamethylmelamine and DNA leads to the crosslinking of DNA strands and inhibits transcription. In this way it prevents the synthesis of new proteins which are required for cell division. It has been used as a chemotherapeutic agent for leukemia and reticulum cell sarcoma but its use has been discontinued due to the toxicity associated with its use.</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>